Medindia

X

Clinical Trial of NewLink and Merck’s Ebola Vaccine Put on Hold

by Dr. Trupti Shirole on  December 12, 2014 at 5:58 PM Clinical Trials News   - G J E 4
Scientists have decided to put a hold on the Swiss clinical trials of Ebola vaccine from NewLink and Merck, where some volunteers reported joint pains.
 Clinical Trial of NewLink and Merck’s Ebola Vaccine Put on Hold
Clinical Trial of NewLink and Merck’s Ebola Vaccine Put on Hold
Advertisement

Global Alliance for Vaccines and Immunization (GAVI) and the Bill and Melinda Gates Foundation, said that they were set to begin procurement of the vaccine as soon as the World Health Organization (WHO) recommended a vaccine for use.

Advertisement
Ebola outbreak has been responsible for death of more than 6000 people in West Africa, and doses of Ebola vaccine may be needed in millions to help put an end to the current epidemic, and also prevent future outbreaks.

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All